TNFSF14-GRAMD1A Fusion FISH Probe
The TNFSF14-GRAMD1A Fusion FISH Probe is used to confirm a fusion of the TNFSF14 and GRAMD1A genes. The fusion of the TNFSF14 and GRAMD1A genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TNFSF14-GRAMD1A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TNFSF14-GRAMD1A-20-AQAQ | 20 (40 μL) | 200 μL |
|
TNFSF14 Gene Summary
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF14, which is a member of the tumor necrosis factor receptor superfamily, and which is also known as a herpesvirus entry mediator (HVEM). This protein may function as a costimulatory factor for the activation of lymphoid cells and as a deterrent to infection by herpesvirus. This protein has been shown to stimulate the proliferation of T cells, and trigger apoptosis of various tumor cells. This protein is also reported to prevent tumor necrosis factor alpha mediated apoptosis in primary hepatocyte. Two alternatively spliced transcript variant encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Gene Name: TNF Superfamily Member 14
Chromosome: CHR19: 6663147 -6670599
Locus: 19p13.3
GRAMD1A Gene Summary
The GRAM Domain Containing 1A (GRAMD1A) gene is located on chr19 :35491245-35517373 at 19q13.11.
Gene Name: GRAM Domain Containing 1A
Chromosome: CHR19: 35491245 -35517373
Locus: 19q13.11
Gene Diseases
The TNFSF14 GRAMD1A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|